Roche closed its acquisition of oncology EHR vendor Flatiron Health, the Swiss pharmaceutical and diagnostics company confirmed April 6.
Roche purchased the New York City-based startup for $1.9 billion on a "fully diluted basis, subject to certain adjustments," according to an April 6 statement.
Under the agreement, Flatiron Health will continue its operations as a separate legal entity. Flatiron Health, founded by two former Google employees and backed by Google's parent company Alphabet, analyzes data it collects from its oncology-specific EHR to improve cancer treatments.
Roche announced its intent to acquire Flatiron Health in February. At the time, Roche already had a 12.6 percent stake in the healthcare startup.
The acquisition will advance both companies' focus on data-driven personalized oncology care, according to Roche officials.